Harvard Bioscience (NASDAQ:HBIO) Stock Passes Below 200 Day Moving Average – Here’s Why

Harvard Bioscience, Inc. (NASDAQ:HBIO) shares crossed below its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $2.58 and traded as low as $1.93. Harvard Bioscience shares last traded at $1.98, with a volume of 83,714 shares changing hands.

Harvard Bioscience Stock Down 2.0 %

The company has a debt-to-equity ratio of 0.52, a current ratio of 2.06 and a quick ratio of 0.91. The business’s fifty day simple moving average is $2.19 and its two-hundred day simple moving average is $2.58. The company has a market cap of $86.36 million, a PE ratio of -6.00 and a beta of 1.27.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in HBIO. GSA Capital Partners LLP purchased a new position in Harvard Bioscience during the third quarter valued at $30,000. SG Americas Securities LLC acquired a new position in shares of Harvard Bioscience during the 3rd quarter worth about $36,000. Avior Wealth Management LLC raised its position in shares of Harvard Bioscience by 1,118.1% during the 3rd quarter. Avior Wealth Management LLC now owns 14,569 shares of the medical instruments supplier’s stock worth $39,000 after purchasing an additional 13,373 shares during the last quarter. Cubist Systematic Strategies LLC purchased a new position in Harvard Bioscience in the 2nd quarter valued at about $40,000. Finally, Landscape Capital Management L.L.C. acquired a new stake in Harvard Bioscience in the 3rd quarter worth about $50,000. Hedge funds and other institutional investors own 80.87% of the company’s stock.

About Harvard Bioscience

Harvard Bioscience, Inc develops, manufactures, and sells technologies, products, and services for life science applications in the United States and internationally. The company offers cellular and molecular technology products, such as syringe and peristaltic infusion pump products; electroporation and electrofusion instruments, amino acid analyzers, spectrophotometers, and other equipment for molecular level testing and research; and precision scientific measuring instrumentation and equipment, including data acquisition systems for cellular analysis, complete micro electrode array solutions for in vivo recordings, and in vitro systems for extracellular recordings.